{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:31:08Z","timestamp":1791246668785,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.3892\/or.2013.2608","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T12:05:50Z","timestamp":1373371550000},"page":"1707-1714","source":"Crossref","is-referenced-by-count":18,"title":["Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma"],"prefix":"10.3892","volume":"30","author":[{"given":"TINGHUA","family":"HU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUI","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENJUAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUO","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILI","family":"HAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILI","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIEQUN","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENGCHENG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QIANQIAN","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEJUN","family":"NAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"key20180107223351_b1-or-30-04-1707","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107223351_b2-or-30-04-1707","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/1541-7786.MCR-09-0317","article-title":"p57KIP2: \u2018Kip\u2019ing the cell under control","volume":"7","author":"Pateras","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20180107223351_b3-or-30-04-1707","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/carcin\/bgr220","article-title":"Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma","volume":"32","author":"Guo","year":"2011","journal-title":"Carcinogenesis"},{"key":"key20180107223351_b4-or-30-04-1707","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1101\/gad.9.6.639","article-title":"Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution","volume":"9","author":"Lee","year":"1995","journal-title":"Genes Dev"},{"key":"key20180107223351_b5-or-30-04-1707","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1054\/bjoc.2000.1549","article-title":"Epigenetic gene deregulation in cancer","volume":"83","author":"Malik","year":"2000","journal-title":"Br J Cancer"},{"key":"key20180107223351_b6-or-30-04-1707","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/PL00000826","article-title":"Negative regulators of cyclin-dependent kinases and their roles in cancers","volume":"58","author":"Lee","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"key20180107223351_b7-or-30-04-1707","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.otohns.2009.10.050","article-title":"Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma","volume":"142","author":"Lee","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key20180107223351_b8-or-30-04-1707","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2407-8-68","article-title":"CDKN1C\/p57kip2 is a candidate tumor suppressor gene in human breast cancer","volume":"8","author":"Larson","year":"2008","journal-title":"BMC Cancer"},{"key":"key20180107223351_b9-or-30-04-1707","first-page":"1537","article-title":"Loss of p57KIP2 is associated with colorectal carcinogenesis","volume":"23","author":"Li","year":"2003","journal-title":"Int J Oncol"},{"key":"key20180107223351_b10-or-30-04-1707","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1158\/0008-5472.CAN-08-0073","article-title":"Down-regulation of p57Kip2 induces prostate cancer in the mouse","volume":"68","author":"Jin","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107223351_b11-or-30-04-1707","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1038\/sj.onc.1205049","article-title":"Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells","volume":"20","author":"Schwarze","year":"2001","journal-title":"Oncogene"},{"key":"key20180107223351_b12-or-30-04-1707","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1101\/gad.11.8.973","article-title":"Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development","volume":"11","author":"Yan","year":"1997","journal-title":"Genes Dev"},{"key":"key20180107223351_b13-or-30-04-1707","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/387151a0","article-title":"Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome","volume":"387","author":"Zhang","year":"1997","journal-title":"Nature"},{"key":"key20180107223351_b14-or-30-04-1707","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nrc1501","article-title":"Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?","volume":"4","author":"Besson","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180107223351_b15-or-30-04-1707","first-page":"1321","article-title":"p57: A multifunctional protein in cancer (Review)","volume":"36","author":"Guo","year":"2010","journal-title":"Int J Oncol"},{"key":"key20180107223351_b16-or-30-04-1707","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1092053","article-title":"Cell migration: integrating signals from front to back","volume":"302","author":"Ridley","year":"2003","journal-title":"Science"},{"key":"key20180107223351_b17-or-30-04-1707","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/bj20031041","article-title":"Rho GTPases have diverse effects on the organization of the actin filament system","volume":"377","author":"Aspenstr\u00f6m","year":"2004","journal-title":"Biochem J"},{"key":"key20180107223351_b18-or-30-04-1707","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(92)90163-7","article-title":"The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors","volume":"70","author":"Ridley","year":"1992","journal-title":"Cell"},{"key":"key20180107223351_b19-or-30-04-1707","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"key20180107223351_b20-or-30-04-1707","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/bies.20238","article-title":"Rho GTPase expression in tumourigenesis: evidence for a significant link","volume":"27","author":"G\u00f3mez del Pulgar","year":"2005","journal-title":"Bioessays"},{"key":"key20180107223351_b21-or-30-04-1707","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbrc.2004.01.108","article-title":"Expression of seven main Rho family members in gastric carcinoma","volume":"315","author":"Pan","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107223351_b22-or-30-04-1707","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1478-3231.2010.02232.x","article-title":"RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N\u2019Rho move it","volume":"30","author":"Wong","year":"2010","journal-title":"Liver Int"},{"key":"key20180107223351_b23-or-30-04-1707","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymthe.2004.08.029","article-title":"Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo","volume":"11","author":"Pill\u00e9","year":"2005","journal-title":"Mol Ther"},{"key":"key20180107223351_b24-or-30-04-1707","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B","article-title":"Rho GTPases are over-expressed in human tumors","volume":"81","author":"Fritz","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107223351_b25-or-30-04-1707","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/jbc.M306968200","article-title":"Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK\/LIMK\/cofilin pathway","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107223351_b26-or-30-04-1707","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000152939","article-title":"p27Kip1 promotes migration of metastatic hepatocellular carcinoma cells","volume":"29","author":"Wang","year":"2008","journal-title":"Tumour Biol"},{"key":"key20180107223351_b27-or-30-04-1707","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1073\/pnas.0805057106","article-title":"RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility","volume":"106","author":"Larrea","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107223351_b28-or-30-04-1707","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/MCB.02061-05","article-title":"The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms","volume":"26","author":"Croft","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180107223351_b29-or-30-04-1707","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1128\/MCB.22.21.7581-7592.2002","article-title":"Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21Cip1\/Waf1 in phorbol 12-myristate-13-acetate-induced apoptotic cells","volume":"22","author":"Lai","year":"2002","journal-title":"Mol Cell Biol"},{"key":"key20180107223351_b30-or-30-04-1707","doi-asserted-by":"crossref","first-page":"26323","DOI":"10.1074\/jbc.M402725200","article-title":"Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1\/S transition","volume":"279","author":"Mammoto","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107223351_b31-or-30-04-1707","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0960-9822(99)80067-0","article-title":"Transformation mediated by RhoA requires activity of ROCK kinases","volume":"9","author":"Sahai","year":"1999","journal-title":"Curr Biol"},{"key":"key20180107223351_b32-or-30-04-1707","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/emboj\/20.4.755","article-title":"Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility","volume":"20","author":"Sahai","year":"2001","journal-title":"EMBO J"},{"key":"key20180107223351_b33-or-30-04-1707","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1541-7786.MCR-08-0248","article-title":"RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors","volume":"7","author":"Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20180107223351_b34-or-30-04-1707","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00016480500388851","article-title":"p57kip2 expression is related to carcinogenesis and tumor progression in laryngeal tissues","volume":"126","author":"Fan","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"key20180107223351_b35-or-30-04-1707","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5301\/JBM.2011.6372","article-title":"Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients","volume":"26","author":"Biaoxue","year":"2011","journal-title":"Int J Biol Markers"},{"key":"key20180107223351_b36-or-30-04-1707","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1524-4741.2009.00860.x","article-title":"Overexpression of RhoA is associated with progression in invasive breast duct carcinoma","volume":"16","author":"Ma","year":"2010","journal-title":"Breast J"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2608\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:42:59Z","timestamp":1515364979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,7,9]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.3892\/or.2013.2608"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2608","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}